Outpatient <scp>CD19‐directed CAR</scp> T‐cell therapy is feasible in patients of all ages-Reference-Cited by-同舟云学术

Outpatient CD19‐directed CAR T‐cell therapy is feasible in patients of all ages

Published:2023-08-29 Issue:4 Volume:203 Page:688-692
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ly Andrew¹^ORCID,Sanber Khaled²,Tsai Hua‐Ling²,Ondo Angela²,Mooney Kathy²,Shedeck Audra²,Baker Julie²,Imus Philip Hollingsworth²,Wagner‐Johnston Nina²^ORCID,Jain Tania²^ORCID

Affiliation:

1. Johns Hopkins University School of Medicine Baltimore Maryland USA

2. Division of Hematological Malignancies and Bone Marrow Transplantation Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Baltimore Maryland USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19090

Reference17 articles.

1. Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

2. Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular Therapy

3. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

4. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

5. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma;Frontiers in Immunology;2024-06-10

2. Axicabtagene-ciloleucel;Reactions Weekly;2024-04-27

3. Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations;Clinical Hematology International;2024-04-09

4. The Implementation of Chimeric Antigen Receptor (CAR) T-cell Therapy in Pediatric Patients: Where Did We Come From, Where Are We Now, and Where are We Going?;Clinical Hematology International;2024-03-13

5. Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy;Transplantation and Cellular Therapy;2024-02